Related Experiment Video
Updated: May 9, 2026
Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Genetic variants and mutations of PPM1D control the response to DNA damage
Crissy Dudgeon1, Sathyavageeswaran Shreeram, Kan Tanoue
1Department of Pediatrics, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Abstract:
The Wip1 phosphatase is an oncogene that is overexpressed in a variety of primary human cancers. We were interested in identifying genetic variants that could change Wip1 activity. We identified 3 missense SNPs of the human Wip1 phosphatase, L120F, P322Q, and I496V confer a dominant-negative phenotype. On the other hand, in primary human cancers, PPM1D mutations commonly result in a gain-of-function phenotype, leading us to identify a hot-spot truncating mutation at position 525. Surprisingly, we also found a significant number of loss-of-function mutations of PPM1D in primary human cancers, both in the phosphatase domain and in the C terminus. Thus, PPM1D has evolved to generate genetic variants with lower activity, potentially providing a better fitness for the organism through suppression of multiple diseases. In cancer, however, the situation is more complex, and the presence of both activating and inhibiting mutations requires further investigation to understand their contribution to tumorigenesis.
Insights
Genetic variants of the Wip1 phosphatase (PPM1D) impact its activity, with some causing dominant-negative effects and others gain-of-function or loss-of-function mutations found in human cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Wip1 phosphatase (PPM1D) is an oncogene overexpressed in various human cancers.
- Understanding genetic variants affecting Wip1 activity is crucial for cancer research.
Purpose of the Study:
- To identify genetic variants of the human Wip1 phosphatase (PPM1D) that alter its enzymatic activity.
- To investigate the functional consequences of these variants in the context of human cancers.
Main Methods:
- Identification of missense single nucleotide polymorphisms (SNPs) in the human Wip1 phosphatase.
- Analysis of mutation types (missense, truncating) and their locations within the PPM1D gene.
- Assessment of functional phenotypes (dominant-negative, gain-of-function, loss-of-function).
Main Results:
- Three missense SNPs (L120F, P322Q, I496V) were found to confer a dominant-negative phenotype.
- A hot-spot truncating mutation at position 525 was identified, commonly associated with a gain-of-function phenotype in cancers.
- A significant number of loss-of-function mutations were also discovered in both the phosphatase domain and C terminus of PPM1D in primary human cancers.
Conclusions:
- PPM1D exhibits diverse genetic variants with opposing functional effects (activating and inhibiting).
- These variants may represent an evolutionary adaptation for disease suppression, but their role in cancer is complex.
- Further research is needed to elucidate the specific contributions of these activating and inhibiting PPM1D mutations to tumorigenesis.
Related Concept Videos
02:36DNA Damage can Stall the Cell Cycle
02:36DNA Damage Can Stall the Cell Cycle
02:23Abnormal Proliferation
01:38Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
01:08Nucleotide Excision Repair
01:20Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...